• 1
    Suh D-C, Kim C-M, Choi I-S et al. Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004. J Am Geriatr Soc 2008;56:484492.
  • 2
    Valdés S, Rojo-Martínez G, Soriguer F. Evolution of prevalence of type 2 diabetes in adult Spanish population. Med Clin 2007;129:352355.
  • 3
    Rastogi R, Saudek C, Brancati F et al. Association of diabetes, comorbidities, and A1C with functional disability in older adults. Diabetes Care 2010;33:10551060.
  • 4
    American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010;33(Suppl 1):S11S61.
  • 5
    de Ruijter W, Westendorp RG, Assendelft WJ et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: Population based observational cohort study. BMJ 2009;338:a3083.
  • 6
    Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129139.
  • 7
    Van den Berg E, de Craen AJM, Biessels J et al. The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population based study. Diabetologia 2006;49:20152023.
  • 8
    Morley JE. Diabetes and aging: Epidemiologic overview. Clin Geriatr Med 2008;24:395405.
  • 9
    Sibal L, Home PD. Management of type 2 diabetes: NICE guidelines. Clin Med 2009;9:353357.
  • 10
    Formiga F, Ferrer A, Megido MJ et al. Low co-morbidity, low levels of malnutrition, and low risk of falls in a community-dwelling sample of 85-year-olds are associated with successful aging: The Octabaix Study. Rejuvenation Res 2011;14:309314.
  • 11
    Migdal A, Yarandi S, Smiley D et al. Update on diabetes in the elderly and in nursing home residents. J Am Med Dir Assoc 2011;12:627632.e2.
  • 12
    Collerton J, Barrass K, Bond J et al. The Newcastle 85+ Study: Biological, clinical and psychosocial factors associated with healthy ageing: Study protocol. BMC Geriatr 2007;7:14.
  • 13
    Zhang X, Decker FH, Luo H et al. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995–2004. J Am Geriatr Soc 2010;58:724730.
  • 14
    Molander L, Lovheim H, Norman T et al. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc 2008;56:18531859.
  • 15
    Ferrer A, Formiga F, Henríquez E et al. Evaluación funcional y cognitiva en una población urbana de mayores de 89 años. Estudio NonaSantfeliu. Rev Esp Geriatr Gerontol 2006;41:2126 (in Spanish).
  • 16
    Roberts RO, Geda YE, Knopman DS et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008;65:10661073.
  • 17
    Mozaffarian D, Kamineni A, Carnethon M et al. Lifestyle risk factors and new-onset diabetes mellitus in older adults: The Cardiovascular Health Study. Arch Intern Med 2009;169:798807.
  • 18
    Cigolle CT, Lee PG, Langa KM et al. Geriatric conditions develop in middle-aged adults with diabetes. J Gen Intern Med 2011;26:272279.
  • 19
    Formiga F. Type 2 diabetes mellitus in the elderly, a great opportunity and many challenges. Rev Esp Geriatr Gerontol 2010;45:179180 (in Spanish).
  • 20
    Bax JJ, Casadei B, Di Mario C et al. Highlights of the 2009 scientific sessions of the European Society of Cardiology. J Am Coll Cardiol 2009;54:24472458.
  • 21
    Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823828.
  • 22
    Sattar N, Preiss D, Murray HM et al. Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials. Lancet 2010;375:735742.
  • 23
    Orozco Beltrán D, de la Sen Fernández C, Guillén VG et al. Diabetes mellitus and cardiovascular risk. Is integrated therapy of type 2 diabetes and cardiovascular risk factors necessary? Aten Primaria 2010;42:1623.
  • 24
    Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 2004;364:685696.
  • 25
    De Jager J, Kooy A, Lehert P et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomised placebo controlled trial. BMJ 2010;340:c2181.
  • 26
    Cesari M, Marzetti E, Laudisio A et al. Interaction of HDL cholesterol concentrations on the relationship between physical function and inflammation in community-dwelling older persons. Age Ageing 2010;39:7480.
  • 27
    Vasto S, Candore G, Balistreri CR et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007;128:8389.
  • 28
    Ford ES. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 2002;155:5764.
  • 29
    Rigalleau V, Beauvieux MC, Gonzalez C et al. Estimation of renal function in patients with diabetes. Diabetes Metab 2011;37:359366.